CompletedPhase 4NCT03508882

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

Studying Hemifacial spasm

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The University of Hong Kong
Principal Investigator
Marcus M Marcet, MD
The University of Hong Kong
Intervention
Botulinum Toxin Type A 100Unit/Vial (Product)(drug)
Enrollment
100 enrolled
Eligibility
18 years · All sexes
Timeline
2015 – 2019

Collaborators

Food and Health Bureau, Hong Kong

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03508882 on ClinicalTrials.gov

Other trials for Hemifacial spasm

Additional recruiting or active studies for the same condition.

See all trials for Hemifacial spasm →

← Back to all trials